Stereotaxis Inc (STXS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Stereotaxis Inc   (NYSEAMER: STXS)


Stereotaxis Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Stereotaxis Inc's ROI in the second quarter of 2026?
Stereotaxis Inc recorded a cumulative net loss of $-22 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -81.47%.

Within the Healthcare sector 564 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3277 to 3911.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 12.72 % 5.87 % -8.22 % -15.56 % -5.89 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 24 31 30 25 20
Return On Investment (TTM) -81.47 % -81.45 % -89.24 % -102.46 % -96.07 %
STXS's Overall Ranking # 3911 # 3277 # 2906 # 3688 # 3291
Seq. Investment Change TTM 2.94 % 9.76 % 5.17 % -5.14 % -3.32 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -22 -22 -22 -24 -23




Return On Investment STXS's Ranking
Within: No.
Industry # 133
Sector # 565
Overall # 3911

Return On Investment Statistics
High Average Low
1.32 %
-642.93 %
-17465.75 %
(Dec 31 2018)   (Dec 31 2013)



  News about Stereotaxis Inc Return on Investment ROI

Hospital da Luz Pioneers Robotic Surgery in Portugal with Genesis Robotic System

November 20, 2024

In a groundbreaking advancement for the field of surgical robotics in Portugal, Hospital da Luz in Lisbon has successfully adopted the Genesis Robotic Magnetic Navigation (RMN) System developed by Stereotaxis, a renowned leader in the realm of minimally invasive endovascular interventions. This landmark achievement marks a significant milestone for both the hospital and the wider medical community in Portugal, as it is the first institution in the country to utilize this cutting-edge technology.On November 20, 2024, Stereotaxis announced that pioneering physicians at Hospital da Luz have initiated a series of procedures utilizing the Genesis RMN System. The successful implementation of this robotic technology is expected to enhance the precision and efficiency of endovascular surgeries, potentially leading to improved outcomes for patients suffering from a variety of vascular conditions.






Financial Statements
Stereotaxis Inc's II. Quarter Investments $ 24 Millions STXS's Balance sheet
Stereotaxis Inc's II. Quarter Income $ -4 Millions Quarterly STXS's Income Statement
STXS's Income by Division See STXS's Income by Division


STXS Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 30 25 29 39 48
Y / Y Investment Growth 18.98 % -12.35 % -26.74 % -18.02 % 13.94 %
Net Income in Millions -22 -24 -21 -18 -11
Y / Y Net Income Growth - - - - -
Annual Return On Investment -72.41 % -95.71 % -72.27 % -46.76 % -22.45 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
STXS's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for STXS's Competitors
Subscribers only: Roi for Stereotaxis Inc's Suppliers
Subscribers only: Return On Investment for STXS's Customers

Other Ratios
STXS's Roa STXS's Inventory Turnover Ratio STXS's Growth Rates STXS's Dividend Statistics
STXS's Profitability Ratios STXS's Asset Turnover Ratio STXS's Dividend Growth
STXS's Roe STXS's Valuation Ratios STXS's Financial Strength Ratios STXS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-04T00:11:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.